Best Reads Of The Week With Brianna Labuskes
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
The independent source for health policy research, polling, and news.
2,261 - 2,280 of 3,938 Results
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
A crowdsourced investigation by KHN and NPR gives voice to those who are puzzled and outraged by medical invoices.
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In a case with possible national repercussions, the stateâs attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. âUnless the metal [was] mined on an asteroid, I do not know why it should cost that amount,â she says.
President Donald Trumpâs much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Childrenâs Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
The complexity of health insurance coverage rules, along with market trends that leave consumers open to more out-of-pocket costs, lead to mounting medical debt for consumers.
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
The scathing report cites a significant increase in cases of poor care â especially ones with the potential to cause serious injuries or death. A state lawmaker called the findings âvery, very disturbing.â
Companies pushed proton machines and counted on advertising, doctors and insurers to ensure a steady business treating cancer. But the dollars havenât flowed in as expected.
The former secretary of the Department of Health and Human Services says the law eliminating penalties for most people who donât have insurance coverage will hurt the insurance marketplaces.
Getting prisoners to a medical facility can be difficult, so corrections officials are increasingly setting up telemedicine programs for specialized needs, such as psychiatric, cancer and cardiac care.
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
President Donald Trumpâs upcoming speech on drug prices comes after months of public comments and debate about tackling the issue.
Nationally, women outnumber men as specialists in obstetrics and gynecology â yet women remain underrepresented in leadership roles. Many OB-GYN patients say they prefer female doctors, as residency programs strive for diversity in race, ethnicity and even gender.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss the collapse of the nomination of White House physician Ronny Jackson to head the Department of Veterans Affairs. They also discuss new bipartisan congressional efforts to address the opioid epidemic. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.
Š 2026 KFF